CASTAGNA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.687
AS - Asia 1.387
EU - Europa 1.231
SA - Sud America 167
AF - Africa 52
OC - Oceania 3
Totale 4.527
Nazione #
US - Stati Uniti d'America 1.646
CN - Cina 416
SG - Singapore 385
DE - Germania 330
IT - Italia 253
GB - Regno Unito 192
VN - Vietnam 156
BR - Brasile 131
HK - Hong Kong 125
SE - Svezia 100
RU - Federazione Russa 99
BD - Bangladesh 90
IN - India 77
FR - Francia 58
NL - Olanda 41
IE - Irlanda 39
FI - Finlandia 33
JP - Giappone 32
CI - Costa d'Avorio 26
ID - Indonesia 23
KR - Corea 22
CA - Canada 20
DK - Danimarca 14
ES - Italia 14
AT - Austria 13
TR - Turchia 13
PL - Polonia 10
UA - Ucraina 10
AR - Argentina 9
CH - Svizzera 8
EC - Ecuador 8
PH - Filippine 8
IQ - Iraq 7
MX - Messico 7
PK - Pakistan 7
TH - Thailandia 6
CL - Cile 5
CO - Colombia 5
ET - Etiopia 4
ZA - Sudafrica 4
CR - Costa Rica 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
SY - Repubblica araba siriana 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
MA - Marocco 2
MY - Malesia 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
SC - Seychelles 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.527
Città #
Ashburn 261
Frankfurt am Main 259
Singapore 196
Southend 164
Chandler 115
Hong Kong 113
Milan 107
San Jose 107
Beijing 69
Dallas 66
Fairfield 53
Los Angeles 50
New York 44
Hanoi 43
Wilmington 43
Princeton 42
Dublin 39
Council Bluffs 38
Ho Chi Minh City 35
Seattle 35
Santa Clara 34
Hefei 29
Woodbridge 28
Houston 27
Abidjan 26
Lauterbourg 23
Munich 23
Ann Arbor 22
Cambridge 22
Helsinki 22
Bengaluru 21
Shanghai 20
Guangzhou 19
The Dalles 19
Tokyo 19
Buffalo 18
Columbus 17
Jakarta 17
Nanjing 17
Moscow 16
Dearborn 15
Seoul 15
Chicago 14
Des Moines 14
São Paulo 13
Da Nang 11
Nuremberg 11
Jinan 10
Naples 10
Phoenix 10
Shenyang 10
Cangzhou 9
Rome 9
Haiphong 8
Toronto 8
Amsterdam 7
Barcelona 7
Falls Church 7
Genoa 7
Istanbul 7
Shenzhen 7
Vienna 7
Falkenstein 6
San Diego 6
Tianjin 6
Wuhan 6
Baghdad 5
Berlin 5
Boardman 5
Florence 5
Fuzhou 5
Kunming 5
Orem 5
Turku 5
Warsaw 5
Addis Ababa 4
Atlanta 4
Bangkok 4
Charlotte 4
Dong Ket 4
Fremont 4
Hangzhou 4
Jiaxing 4
Kent 4
London 4
Magenta 4
Mumbai 4
Ninh Bình 4
Philadelphia 4
Stockholm 4
Taizhou 4
Washington 4
Wroclaw 4
Xian 4
Zurich 4
Andover 3
Belo Horizonte 3
Belém 3
Bühl 3
Catania 3
Totale 2.698
Nome #
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation 429
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 279
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide 271
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC 265
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy 249
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 231
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis 201
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT 199
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry 185
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas 184
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand 182
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 169
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 163
Re-discovering NK cell allo-reactivity in the therapy of solid tumors 150
Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies 150
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation : an Italian Prospective Multicenter Survey 143
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party 127
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide 126
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 115
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 113
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party 113
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT 104
Outcome of Allogeneic Transplantation for Mature T-cell Lymphomas: Impact of Donor Source and Disease Characteristics 101
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry‐Based Study on Behalf of the “Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare” (GITMO) 90
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma : a registry study by the European society for blood and marrow transplantation 90
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis 86
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 85
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma : a retrospective study of the Lymphoma Working Party—EBMT 72
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis 28
Totale 4.700
Categoria #
all - tutte 14.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 24 20
2021/2022369 22 34 49 18 30 40 24 22 46 23 10 51
2022/2023412 42 49 60 34 34 82 5 22 42 2 26 14
2023/2024449 24 20 6 38 91 26 53 38 19 34 51 49
2024/2025780 38 70 26 85 44 28 24 76 42 81 65 201
2025/20262.015 237 130 208 139 146 96 242 73 171 112 461 0
Totale 4.700